baber/WOPTO huggingface dataset:
Patent EP-3784019-A1 (EP)
Inventor: RICO VINCENT
IPC: A01D46/28
Filed: 2019-04-26
Abstract: The invention relates to a system for cleaning a flow of harvested crop, said system comprising a conveyor (9) arranged to convey said flow downstream of said conveyor into a cleaning zone (Z) into which said flow is intended to be discharged, and a suction cleaning unit (10) located above said cleaning zone and operable to generate an upward air flow through said cleaning zone for extracting residues (L) contained in said discharged flow, said system further comprising at least two conveying rolls (11a, 11b) that are disposed behind the downstream end of the conveyor (9) in an upstream part (Za) of the cleaning zone in order to be fed with the flow of harvested crop discharged from the conveyor (9), said conveying rolls being arranged to convey said crop flow and to discharge it into a downstream part (Zb) of the cleaning zone (Z), wherein passages (P) are formed between or through said rolls, said passages being arranged to allow an upward air flow (A) therethrough for extracting residues (L) from the crop present on the conveying rolls (11a, 11b).
Patent EP-3781199-A1 (EP)
Inventor: YONAN CHRIS
IPC: A61K39/395
Filed: 2019-04-17
Abstract: The invention provides buffered aqueous formulations of bevacizumab. The invention further provides methods of making buffered formulations of bevacizumab. The invention provides methods of treating eye disorders, particularly wet age-related macular degeneration and macular edema by administering the buffered antibody compositions of the disclosure.
Patent EP-3803767-A1 (EP)
Inventor: BILLETER SALOMON
IPC: G06Q40/08
Filed: 2019-06-05
Abstract: Proposed is a passage-based risk splitter (11) providing risk splitting and loss event diversification for multi-risk forecast systems (1) capturing multiple loss aggregation under complex environmental conditions based on the occurrence of defined loss events (44). The loss events (44) are triggered by one or more involved causing units (4) and affected units (3), wherein the loss events (44) evolve from one or multiple risk accumulating sources. Risk events (44) related loss measures can be scattered over multiple causing units (4) and/or multiple related clash events (44). The multi-risk forecast system (1) provides loss-generating processes and events (44), wherein the inventive risk splitter (11) is a technical core element to generate an event-related loss distribution (112) mirroring cause-effect chains (100) induced by the risk events (44) which extend over space and time. The risk splitter module (11) allows automated splitting of the risk based on risk exposed, causing unit characteristics (111) and risk exposed affected units' characteristics (112). The causing unit characteristics (111) comprise, for each causing unit (4), assigned activity characteristic parameters (1110) and participation characteristic parameters (1111) of said causing unit (4) defining, for a specific causing unit (4), a specific set of executable activity link members (1112) and market share driving participation probabilities (1113). The causing unit characteristics (112) comprises quota parameters defining affected populations of affected units (3) with incidence (1121) and defining refined effect types (1122).
Patent EP-3732936-A1 (EP)
Title: Heat-not-burn device and method
Inventor: CHONG ALEXANDER CHINHAK
IPC: A24F40/53
Filed: 2019-01-03
Abstract: A device for converting a consumable into an aerosol with high heat without burning the consumable by packaging the consumable containing an internal susceptor inside an encasement having a plurality of holes with an induction heating element wrapped around the consumable-containing package to heat the susceptor using a magnetic field generated by the induction heating element. Combustion of the consumable-containing package is minimized by limiting air inside the consumable-containing package by coating the encasement material that melts at high temperatures. The coating may also include a flavoring. Efficiency of the device can be enhanced with a self-resonant oscillator, moving coils, multi-prong susceptors, sensors, heat dissipation, air flow control, alignment mechanisms, and the like.
Patent EP-3815115-A1 (EP)
Inventor: STEVENS GARY
IPC: H01B3/00
Filed: 2019-06-27
Abstract: The disclosure provides an electrically insulating composite material comprising a thermoplastic or thermoset and hexagonal boron nitride (h-BN). The weight ratio of the thermoplastic or thermoset to h-BN is between 90:10 and 99.5:0.5 and the electrically insulating composite material has a resistivity of at least 1x10 12  Ωm at 60°C.
Patent EP-3741109-A1 (EP)
Inventor: MILLER SAMUEL A
IPC: H04N13/128
Filed: 2019-01-17
Abstract: A display system can include a head-mounted display configured to project light to an eye of a user to display virtual image content at different amounts of divergence and collimation. The display system can include an inward-facing imaging system images the user's eye and processing electronics that are in communication with the inward-facing imaging system and that are configured to obtain an estimate of a center of rotation of the user's eye. The display system may render virtual image content with a render camera positioned at the determined position of the center of rotation of said eye.
Patent EP-3823618-A1 (EP)
Title: Methods of use of ultra-high dose rate radiation and therapeutic agents
Inventor: PARRY RENATE
IPC: A61K31/436
Filed: 2019-07-19
Abstract: Methods for treating tumors by administering FLASH radiation and a therapeutic agent to a patient with cancer are disclosed. The methods provide the dual benefits of anti-tumor efficacy plus normal tissue protection when combining therapeutic agents with FLASH radiation to treat cancer patients. The methods described herein also allow for the classification of patients into groups for receiving optimized radiation treatment in combination with a therapeutic agent based on patient-specific biomarker signatures. Also provided are radiation treatment planning methods and systems incorporating FLASH radiation and therapeutic agents.
Patent EP-3751235-A1 (EP)
Inventor: SATO KENJI
IPC: G01D9/00
Filed: 2019-01-31
Abstract: To allow a time-series change among signal values to be recorded easily for a process of recording the respective time-series values of input signals, a recording device includes: a determination reference value obtaining section configured to obtain a determination reference value on a basis of signal values during a reference time period, the reference time period being a predetermined time period after a start of input of time-series signal values, the determination reference value indicating a feature of the signal values during the reference time period, and a recording control section configured to (i) obtain information on a recording start condition on a basis of the determination reference value, the recording start condition indicating whether, as compared to the signal values during the reference time period, there has been a large change among signal values after the reference time period has elapsed, and (ii) start recording signal values in response to the recording start condition becoming satisfied.
Patent EP-3709740-A1 (EP)
Title: Method for transmitting downlink control information
Inventor: LI JUNCHAO
IPC: H04L5/00
Filed: 2019-02-02
Abstract: This application provides a downlink control information transmission method and an apparatus. The method includes: receiving first downlink control information DCI in search space of a first carrier bandwidth part BWP, where if a frequency domain resource allocation type of the first BWP is a type 0, an  L f   -bit frequency domain resource allocation indication in the first DCI is an  L f    -bit bitmap, and bits in the  L f    - bit bitmap in descending order are respectively corresponding to resource block groups RBG 0 to RBG ( L f    -1) in a second BWP; and for one bit in the  L f    -bit bitmap, when a value of the bit is t1, an allocated resource includes one RBG corresponding to the bit. According to this method, BWP switching or cross-BWP scheduling can be performed by using a truncated information field.
Patent EP-3829910-A1 (EP)
Inventor: MARECHAL OLIVIER
IPC: B60K1/02
Filed: 2019-08-01
Abstract: Electric vehicle propulsion system (1), comprising: – a first electric propulsion motor (10), comprising a stator and a rotor having a first output shaft able to move in rotation about a first axis, – a second electric propulsion motor (11) comprising a stator and a rotor having a second output shaft able to move in rotation about a second axis, – a first reduction gearbox (21) able to receive the torque supplied by the first electric motor (10), if appropriate via a first selective or non-selective coupling system (20), this first reduction gearbox (21) having a first reduction ratio, – a second reduction gearbox (23) able to receive the torque supplied by the second electric motor (11), where appropriate via a second selective or non-selective coupling system (22), this second reduction gearbox (23) having a second reduction ratio, and – a third coupling system (35) which may or may not be selective, for coupling the first output shaft and the second output shaft, the first axis and the second axis not being coincident.
Patent EP-3847149-A1 (EP)
Inventor: VANDEN EYNDE JOHAN
IPC: C07C37/20
Filed: 2019-08-15
Abstract: The present invention relates to the preparation of 3,3,5 -trimethylcyclohexylidene bisphenol (BP-TMC). Especially, the present invention relates to the preparation of 3,3,5-trimethylcyclohexylidene bisphenol (BP-TMC) from 3,3,5 -trimethy lcyc lohexanone (TMC-one) and phenol in the presence of a gaseous acidic catalyst. The preparation is preferably conducted continuously. It is an object of the present invention to prevent that solids, especially crystallized BP-TMC, more especially crystallized BP-TMC-phenol-adduct, block the outlet of the dosing valve for the gaseous acidic acid when the gaseous acidic acid is dosed into the reaction mixture comprising TMC-one and phenol in a reaction vessel.
Patent EP-3847039-A1 (EP)
Inventor: GOUEREC JULIEN
IPC: B43K19/14
Filed: 2019-09-06
Abstract: The present invention relates to a body for a writing, tracing, drawing or coloring pencil, the composition of which comprises, by weight, with respect to the total weight of the body: - a) between 50% and 95% of a mixture of polylactic acid and of polybutylene succinate in a polylactic acid/polybutylene succinate ratio by weight of between 90/10 and 60/40 and - b) between 5% and 50% of filler, wherein said filler comprises an organic filler, such as wood fibers. In addition, it relates to a writing, tracing, drawing or coloring pencil comprising this body.
Patent EP-3841811-A1 (EP)
Inventor: LEE MOON-IL
IPC: H04L5/00
Filed: 2019-08-21
Abstract: Methods and apparatus for wireless transmit/receive unit (WTRU) power control are described. A method includes receiving a time domain resource allocation (TDRA) list configuration including entries, each including a resource allocation that includes a slot offset value. L1 signaling is received indicating a minimum slot offset value. Downlink control information (DCI) is decoded on a physical downlink control channel in a slot. An index is obtained from the decoded DCI, identifying an entry in the TDRA list. A particular slot offset value identified by the index is retrieved from the TDRA list and compared with the minimum slot offset value. If the particular slot offset value is less than the minimum slot offset value, the entry is invalid. If the particular slot offset value is greater than or equal to the minimum slot offset value, a physical downlink shared channel is received.
Patent EP-3768281-A1 (EP)
Inventor: BONIFANT CHALLICE
IPC: A61K51/08
Filed: 2019-03-19
Abstract: Chimeric antigen receptors (CARs) are provided that comprise a CD123-specific antigen recognition domain and IL7Ra transmembrane and intracellular signaling domains (CD123/IL7Ra CARs). In particular embodiments, provided herein are engineered lymphocytes that express and display CD123/IL7Ra CARs, and methods of targeting CD123-positive leukemic cells and treating leukemias, such as acute myeloid leukemia (AML), therewith.
Patent EP-3770230-A1 (EP)
Title: Water repellent composition
Inventor: TAKEWAKI KAZUYUKI
IPC: C08G77/44
Filed: 2019-02-14
Abstract: The present invention is a water repellent composition containing (A) a component that is a condensation reaction product between: (a) an organopolysiloxane shown by the following general formula (1) and having a hydroxyl group or an alkoxy group at both terminals of a molecular chain of the organopolysiloxane, (R<sup>2</sup>O)R<sup>1</sup><sub>2</sub>SiO-(R<sup>1</sup><sub>2</sub>SiO)<sub>m</sub>-SiR<sup>1</sup><sub>2</sub>(OR<sup>2</sup>) (1) ; and (b) a trialkylsiloxysilicate containing an R<sup>1</sup><sub>3</sub>SiO<sub>1/2</sub> unit, an SiO<sub>2</sub> unit, and a siloxane unit having a hydroxyl group bonded to a silicon atom, where a molar ratio of the R<sup>1</sup><sub>3</sub>SiO<sub>1/2</sub> unit/the SiO<sub>2</sub> unit is 0.6 to 1.3, and a content of the hydroxyl group is 0.1 or more and less than 2.0 mass%. This provides a water repellent composition which is effectively used as a water repellent excellent in water repellency, particularly suitably applied as an agent for paintwork and a glass surface of an automobile, so as to impart favorable initial water repellency and long-lasting water repellency.
Patent EP-3754283-A1 (EP)
Inventor: DONOSHITA Yuka
IPC: A61L2/18
Filed: 2019-03-18
Abstract: A drug-containing capsule (20, 30, 40) includes a capsule material (21, 31, 41) and a drug (22, 32, 42) disposed within the capsule material (21, 31, 41) and having a sterilization action for a specific microorganism. The capsule material (21, 31, 41) includes a degradable part (21a, 31a, 41a) formed of a raw material that is caused to biodegrade by the specific microorganism. This results in suppression of release of the drug while the specific microorganism does not proliferate.
Patent EP-3775410-A1 (EP)
Title: Wear member, edge and process of installation
Inventor: WOOD CLINTON ANTHONY
IPC: E02F9/24
Filed: 2019-03-29
Abstract: Shrouds are secured to earth-working edges of many kinds of earth working equipment to extend the service life of the equipment. The shrouds include opposed surfaces to define a cavity to receive the edge. Each of the opposed surfaces includes a recess to receive a boss on the edge, wherein the longitudinal axis of the recess on the first surface is angularly oriented in a lateral direction to the longitudinal axis of the recess on the second surface.
Patent EP-3780903-A1 (EP)
Inventor: OTSUKA TATSUYA
IPC: H05B3/02
Filed: 2019-03-19
Abstract: Provided is a film heater which is easy to manufacture and is capable of being easily adhesively attached to an adherend even having an uneven shape, without impairing aesthetic quality of the adherend. In the film heater, a conductive pattern composed of a conductive wire is provided on one surface of a support sheet composed of a transparent thermoplastic resin sheet, wherein the conductive pattern is configured such that a connection terminal section, a lead wire extending from the connection terminal section and a heater section continuing from the lead wire are provided as a continuous linear pattern composed of a single conductive wire.
Patent EP-3867779-A1 (EP)
Inventor: MADDIPATI SRINIVASA
IPC: H04L29/06
Filed: 2019-09-18
Abstract: A computing system includes a server comprising email policy rules to be applied to emails containing sensitive information, a mail server to provide the emails, and a client computing device enrolled with the server to access the mail server. An email privacy filter is to be applied to emails from the mail server intended for the client computing device. The email privacy filter interfaces with the server to receive the email policy rules therefrom. The email privacy filter identifies sensitive information within the email. The email privacy filter then applies the email policy rules, in response to identification of sensitive information within the email, to determine if the email is to be hidden from view on the client computing device so as to prevent display of the sensitive information to an unauthorized viewer.
Patent EP-3774828-A1 (EP)
Title: Terpene glycoside derivatives and uses thereof
Inventor: Gan xian-wen
IPC: C07H1/08
Filed: 2019-09-25
Abstract: The present disclosure relates generally to terpene glycosides, such as certain such compounds extracted from  Stevia rebaudiana Bertoni, Rubus suavissimus, or Siraitia 
 grosvenorii . The disclosure also provides for the use of such compounds as food ingredients, flavors, and sweeteners, and related methods. The disclosure also provides ingestible compositions comprising such compounds, as well as processes for extracting such compounds selectively from certain plant sources.
Patent EP-3866596-A1 (EP)
Inventor: THOMAS HOWARD
IPC: A01N37/46
Filed: 2019-10-18
Abstract: The present invention relates to pharmaceutical compositions and their use for preventing, eradicating or ameliorating infections.More particularly, the compositions comprise one or more flavonoids, such as naringin and neohesperidine and caprylic acid and/or polylysine. Such compositions can, for example, be employed for reducing or eliminating bacteria, fungi and other parasites from water, such as water intended for drinking or from food.
Patent EP-3871475-A1 (EP)
Title: Plasma-behandlungsgerät
Inventor: WANDKE DIRK
IPC: H05H1/24
Filed: 2019-10-23
Abstract: Ein Plasma-Behandlungsgerät (1), ausgebildet zur Behandlung einer Oberfläche mit einem dielektrisch behinderten Plasma, mit einem Grundkörper (3), der mindestens eine flächige und der zu behandelnden Oberfläche zugewandte Behandlungsseite (5) aufweist, und mit einer mindestens eine Elektrode (7) aufweisenden Elektrodenanordnung (9) und mit einem Dielektrikum, das die mindestens eine Elektrode (7) zu der zu behandelnden Oberfläche hin vollständig abdeckt, und mit einer mindestens eine Hochspannungszuleitung (13, 13a, 13b) umfassenden Leitungsanordnung, wobei die Elektrode (7) mit der Leitungsanordnung verbunden ist und über die Hochspannungszuleitung (13, 13a, 13b) mit einem an die Hochspannungszuleitung (13,13a, 13b) anlegbaren Hochspannungssignal beaufschlagt werden kann, und mit einer an der Behandlungsseite (5) des Grundkörpers (3) angeordneten Noppenanordnung (15), die eine Vielzahl von Noppen (17) aufweist, ermöglicht in einfacher Weise die Kombination einer effektiven Plasmabehandlung mit einer effektiven mechanische Behandlung der zu behandelnden Oberfläche dadurch, dass sich die mindestens eine Elektrode (7) der Elektrodenanordnung (9) in mindestens eine Noppe (17) der Noppenanordnung (15) hinein erstreckt.
Patent EP-3787726-A1 (EP)
Title: Sleep phase dependent temperature control and learning methods to optimize sleep quality
Inventor: TSERN ELY
IPC: A47C21/04
Filed: 2019-05-01
Abstract: A bed includes components to control temperature of a sleep surface, for example based on time and historical usage patterns by a user. In some embodiments the temperature of the sleep surface is controlled based on information indicating a sleep state of the user. In some embodiments the temperature is dynamically adjusted so to achieve particular sleep states and/or sleep patterns for the user. In some embodiments the temperature and timing of temperature adjustments is iteratively adjusted over multiple sleep sessions so to achieve improvements in sleep states and/or sleep quality for the user.
Patent EP-3787613-A1 (EP)
Title: Pkc pathway in parkinson's disease
Inventor: LAPERLE ALEXANDER
IPC: A61K31/22
Filed: 2019-04-05
Abstract: Induced Pluripotent Stem Cell (iPSC) technology enables the generation and study of living brain tissue relevant to Parkinson's disease (PD) ex vivo. Utilizing cell lines from PD patients presents a powerful discovery system that links cellular phenotypes observed in vitro with real clinical data. Differentiating patientderived iPSCs towards a dopaminergic (DA) neural fate revealed that these cells exhibit molecular and functional properties of DA neurons in vitro that are observed to significantly degenerate in the substantia nigra of PD patients. Clinical symptoms that drive the generation of other relevant cell types may also yield novel PDspecific phenotypes in vitro that have the potential to lead to new therapeutic avenues for patients with PD. Due to their early onset and nonfamilial origin, differentiated nervous tissue from these patients offer a key opportunity to discover neuron subtypespecific pathological mechanisms and importantly interrogate the contribution of their genetic background in susceptibility to PD.
Patent EP-3874758-A1 (EP)
Inventor: ANDERSSON KENNETH
IPC: H04N19/86
Filed: 2019-10-29
Abstract: A deblocking the method. The method includes deblocking a block boundary between a first block, B1, and a second block, B2, with the restriction that not more than 5 samples are modified on the B2 side of the block boundary as a result of the deblocking. The deblocking method also includes deblocking a sub-block boundary within the B2 block such that not more than 2 samples on the side of the sub-block boundary within the B2 block that is closest to the block boundary between B1 and B2 are modified by the deblocking.
Patent EP-3791918-A1 (EP)
Inventor: KOBAYASHI YUKA
IPC: A61M37/00
Filed: 2019-04-10
Abstract: Provided is a method of producing a microneedle array unit which is capable of suppressing damage to a microneedle array. The method of producing a microneedle array unit, including an array preparing step of preparing a microneedle array which includes a sheet and a plurality of needles arranged on one surface of the sheet; a container preparing step of preparing a container which includes an accommodating portion defining an opening and a space for accommodating the microneedle array, and a deformable portion disposed on a side opposite to the opening and integrated with the accommodating portion; an accommodating step of accommodating the microneedle array in the accommodating portion of the container by allowing the other surface of the sheet of the microneedle array and the deformable portion of the container to oppose each other; and a deforming step of deforming an outer surface of the accommodating portion inward, which is positioned between the one surface of the sheet of the microneedle array and the opening of the accommodating portion, to form a protrusion that reduces an area of the opening.
Patent EP-3867606-A1 (EP)
Inventor: HASE ANTHONY
IPC: G01F25/00
Filed: 2019-10-15
Abstract: An apparatus and method for use in determining one or more fluid flow properties of a fluid in a conduit is disclosed. The apparatus includes a substrate including a barrier, a first flow sensor coupled to the substrate and a second flow sensor coupled to the substrate. The first flow sensor is located at a first sensor distance from a first barrier surface, and the second flow sensor is located a second sensor distance from the second barrier surface. The first sensor distance is substantially equal to the second sensor distance. In operation, the first flow sensor produces a first sensor signal, and the second flow sensor produces a second sensor signal. The direction of flow for the fluid is determined by comparing the first sensor signal to the second sensor signal.
Patent EP-3883641-A1 (EP)
Inventor: PAJUNK-SCHELLING SIMONE
IPC: A61N1/36
Filed: 2019-11-12
Abstract: Multi-polar cannula (10, 10') having a cannula tube (12) with a distal end (14) and a proximal end and with a first electrode (22) and at least one second electrode (24, 26, 28a, 28b, 28c), wherein the cannula tube (12) has a cannula tube body (18) and a layer (20) that electrically insulates the first and second electrodes (22, 24) from each other, wherein the distal end (14) of the cannula tube (12) has a distal tip (16), wherein the first electrode (22) is formed by the cannula tube body (18), and wherein the first electrode (22) and the second electrode (24) are connectable to a bioimpedance meter.